血管纤维化的分子机制及研究进展
DOI:
作者:
作者单位:

(1.河北医科大学研究生院,河北省石家庄市050000;2.云南大学附属医院心血管内科,云南省昆明市 650000)

作者简介:

胡凤丽,博士,研究方向为心血管病,E-mail:1026843851@qq.com。

通讯作者:

基金项目:

河北省重点研发计划项目(223777148D)


Molecular mechanism and research progress of vascular fibrosis
Author:
Affiliation:

1.Graduate School of Hebei Medical University, Shijiazhuang, Hebei 050000, China;2.Department of Cardiovascular Medicine, Affiliated Hospital of Yunnan University, Kunming, Yunnan 650000, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    血管纤维化是心血管疾病进展的核心病理过程,其特征为血管壁中细胞外基质(ECM)的异常沉积与重塑,最终导致血管弹性丧失、血流动力学紊乱及终末器官损伤。该过程涉及血管平滑肌细胞(VSMC)表型转化、内皮-间质转化(EndMT)及炎症纤维化网络激活,其机制包括多细胞交互、信号通路串扰及表观遗传调控。本文系统综述了血管纤维化的病理生理基础、关键的分子及信号网络,结合当前研究现状,探讨了潜在治疗靶点与临床转化挑战,并对未来发展方向进行了展望。

    Abstract:

    Vascular fibrosis is the core pathological process of cardiovascular disease progression, which is characterized by abnormal deposition and remodeling of extracellular matrix (ECM) in the vascular wall. This results in the loss of vascular elasticity, hemodynamic derangement, and end-organ damage. This process involves the phenotypic transformation of vascular smooth muscle cell (VSMC), endothelial-mesenchymal transition (EndMT), and activation of inflammatory-fibrotic networks. The mechanisms include multicellular interactions, signaling pathway crosstalk, and epigenetic regulation. This article systematically reviews the pathophysiological basis, key molecules and signaling networks of vascular fibrosis, discusses potential therapeutic targets and clinical translation challenges based on current research status, and provides an outlook on future development directions.

    参考文献
    相似文献
    引证文献
引用本文

胡凤丽,王鹏飞,陆梅,张新金.血管纤维化的分子机制及研究进展[J].中国动脉硬化杂志,2026,34(3):271~276.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2025-04-27
  • 最后修改日期:2025-07-05
  • 录用日期:
  • 在线发布日期: 2026-04-10